Biliary Tract Cancer Clinical Trials in München
3 recruitingMünchen, Germany
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Biliary Tract Cancer
AstraZeneca1,100 enrolled168 locationsNCT07221253
Recruiting
Phase 2
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer
Biliary Tract CancerHER2HER2 Gene Mutation
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest24 enrolled7 locationsNCT06178445
Recruiting
Phase 2
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Colorectal, CancerGastric CancerBiliary Tract Cancer+4 more
AstraZeneca582 enrolled95 locationsNCT05489211